Thus, HIF-1α has been well-documented for its important role in supporting metastasis and drug resistance in breast cancer, and inhibition of this protein has been regarded as an essential strategy in breast cancer treatment [35]. This evidence concerns the gene HIF1A and breast carcinoma.